Literature DB >> 1984998

Helicobacter pylori and Zollinger-Ellison syndrome.

Z A Saeed1, D J Evans, D G Evans, M J Cornelius, P N Maton, R T Jensen, D Y Graham.   

Abstract

Helicobacter pylori (previously Campylobacter pylori) is almost invariably associated with chronic duodenal ulcer disease. The relationship between H. pylori infection and duodenal ulcer in Zollinger-Ellison syndrome is unknown. We investigated the frequency of H. pylori infection in Zollinger-Ellison syndrome and also what effect H. pylori infection had on gastric function in patients with Zollinger-Ellison syndrome. H. pylori infection was diagnosed based on a specific serologic (ELISA) assay based on high-molecular-weight cell-associated proteins of H. pylori. We studied 20 patients with Zollinger-Ellison syndrome; 15 men and 5 women ranging in age from 24 to 71 years, median age 51. Six Zollinger-Ellison syndrome patients had H. pylori infection compared to 100 consecutive patients with chronic recurrent duodenal ulcer disease (P less than 0.05). Pretreatment basal acid output in Zollinger-Ellison syndrome patients ranged from 7.9 to 95.0 mmol/hr, median 35.2. Pentagastrin-stimulated maximal acid output ranged from 8.5 to 132 mmol/hr; median 52.7. Acid secretion was lower in the H. pylori-infected patients than the uninfected patients (BAO 24.5 +/- 6.5 vs 45.4 +/- 6.6, and MAO 44.3 +/- 11.8 vs 67.9 +/- 10.7, for H. pylori infected vs uninfected patients, respectively). The difference in BAO was statistically significant (P less than 0.05). The present results indicate that H. pylori is not a major contributing factor in duodenal ulcer associated with Zollinger-Ellison syndrome. The association of a reduced BAO with H. pylori suggests that these findings may be related.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984998     DOI: 10.1007/bf01300080

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome.

Authors:  R A GREGORY; H J TRACY; J M FRENCH; W SIRCUS
Journal:  Lancet       Date:  1960-05-14       Impact factor: 79.321

2.  Zollinger-Ellison syndrome treated with poldine methyl methosulphate.

Authors:  R S LAWRIE; A W WILLIAMSON; J N HUNT
Journal:  Lancet       Date:  1962-05-12       Impact factor: 79.321

3.  Parietal and chief cell populations in four cases of the Zollinger-Ellison syndrome.

Authors:  P Neuburger; M Lewin; C de Recherche; S Bonfils
Journal:  Gastroenterology       Date:  1972-12       Impact factor: 22.682

4.  Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease.

Authors:  D Y Graham; P D Klein; A R Opekun; T W Boutton
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

Review 5.  Chronic gastritis: dynamic and clinical aspects.

Authors:  M Siurala; P Sipponen; M Kekki
Journal:  Scand J Gastroenterol Suppl       Date:  1985

Review 6.  Zollinger-Ellison syndrome. Current concepts in diagnosis and management.

Authors:  M M Wolfe; R T Jensen
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

7.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

8.  Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.

Authors:  M J Collen; J M Howard; K E McArthur; J P Raufman; M J Cornelius; C A Ciarleglio; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Spontaneous achlorhydria with atrophic gastritis in the Zollinger-Ellison syndrome.

Authors:  H G Desai; F P Antia
Journal:  Gut       Date:  1969-11       Impact factor: 23.059

View more
  5 in total

1.  Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?

Authors:  Helge L Waldum; Tom C Martinsen; Oyvind Hauso; Gunnar Qvigstad
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 2.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

3.  Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome.

Authors:  D C Metz; H C Weber; M Orbuch; D B Strader; I A Lubensky; R T Jensen
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

4.  Helicobacter pylori in duodenal ulcer patients with idiopathic gastric acid hypersecretion.

Authors:  M J Collen; R M Strong
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

Review 5.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.